The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species.

Source:http://linkedlifedata.com/resource/pubmed/id/11535817

Proc. Natl. Acad. Sci. U.S.A. 2001 Sep 11 98 19 10833-8

Download in:

View as

Triples

General Info

PMID
11535817